EGFR targeting monoclonal antibody combines with an mTOR inhibitor and potentiates tumor inhibition by acting on complementary signaling hubs.

Eight genes involved in the mTOR and EGFR signaling pathway which also showed significant difference in microarray from the control ranging from moderately significant to highly significant ( P -value < 0.05–0.000) were chosen for validating the microarray data.

also in 2,182 other papers